Cui Ling Wu

Chairman at

Guangzhou Fulengen Co., Ltd.

64 year

Health Technology

Consumer Services

Profile

Presently, Cui Ling Wu holds the position of Chairman-Supervisory Board of Guangzhou Wondfo Biotech Co., Ltd. and Chairman of Guangzhou Fulengen Co., Ltd. She is also on the board of Da An Gene Co., Ltd. of Sun Yat-sen University and Deputy Director at Guangzhou Bio-tech Pharmaceuticals Center and Professor at Sun Yat-Sen University. She received an undergraduate degree from Guangdong Pharmaceutical University.

Cui Ling Wu active positions

Companies	Position	Start
Sun Yat-Sen University Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	08/03/2010
Guangzhou Bio-tech Pharmaceuticals Center	Corporate Officer/Principal	28/02/2001
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases.	Chairman	-

All active positions of Cui Ling Wu

Former positions of Cui Ling Wu

Companies	Position	End
DAAN GENE CO., LTD.	Director/Board Member	26/05/2022
GUANGZHOU WONDFO BIOTECH CO.,LTD	Chairman	-

See the detail of Cui Ling Wu's experience

Training of Cui Ling Wu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cui Ling Wu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Daan Gene Co., Ltd. Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment	Health Technology
Guangzhou Bio-tech Pharmaceuticals Center
Guangzhou Wondfo Biotech Co., Ltd. Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits	Health Technology
Sun Yat-Sen University Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Guangdong Pharmaceutical University Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases.